Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Core Viewpoint - Kiniksa Pharmaceuticals International, plc will host a conference call on July 29, 2025, to discuss its second quarter 2025 financial results and recent portfolio execution [1]. Group 1: Conference Call Details - The conference call will take place at 8:30 a.m. Eastern Time [1]. - A live webcast will be available on the company's website, and participants can register for telephone access [2]. - A replay of the event will be accessible on Kiniksa's website approximately 48 hours after the call [2]. Group 2: Company Overview - Kiniksa is a biopharmaceutical company focused on developing therapies for debilitating diseases, particularly in cardiovascular indications [3]. - The company aims to discover, acquire, develop, and commercialize novel therapies for diseases with unmet needs [3]. - Kiniksa's portfolio is based on strong biological rationale or validated mechanisms, offering potential for differentiation in the market [3].